Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral ImmunotherapyCompany founded by 4BIO Capital and ...

Press Release4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral ...

An experimental vaccine showed promise in treating aggressive breast cancer, while a new gene therapy method advances ...

NexCAR19 CAR-T treatment is being developed in India by IIT Bombay, Tata Memorial Centre, and industry partner immunoACT.

Researchers have combined two gene editing methods. This enables them to quickly investigate the significance of many genetic mutations involved in the development and treatment of cancer.

To improve long-term persistence and reduce the risk of immune rejection, researchers are exploring ways to diminish the ...

Elevidys, a gene therapy from ... to develop StitchR treatments for other diseases caused by large genes. Nerve protection ...

The Mass General Brigham Gene and Cell Therapy Institute, a hub of innovation dedicated to accelerating groundbreaking research, conducting clinical trials and developing FDA-approved treatments, ...

Discover a study that aims to customise CIC profiles for patients, providing insights into which stages of the cycle are most ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

However, several years later, five of the 20 children had developed cancer due to an oncogene ... The approval was a big step for the gene therapy market, with the treatment providing a good ...

Researchers from the Walter and Eliza Hall Institute (WEHI)in Australia have found a new way to predict a subset of patients ...